COM:REGULUSRX
Regulus Therapeutics
- Stock
Last Close
1.40
22/11 21:00
Market Cap
115.22M
Beta: -
Volume Today
288.02K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -56.68M - | -55.75M 1.64% | -81.84M 46.80% | -71.91M 12.14% | -48.71M 32.26% | -18.59M 61.83% | -15.73M 15.39% | -27.81M 76.78% | -28.32M 1.85% | -30.04M 6.05% | |
depreciation and amortization | 1.49M - | 1.59M 6.78% | 2.28M 43.05% | 2.52M 10.90% | 2.26M 10.38% | 931K 58.84% | 467K 49.84% | 459K 1.71% | 122K 73.42% | 70K 42.62% | |
deferred income tax | 5.10M - | -15.27M 399.59% | 666K 104.36% | 349K 47.60% | 148K 57.59% | -662K - | |||||
stock based compensation | 7.04M - | 15.37M 118.33% | 12.87M 16.24% | 7.64M 40.63% | 5.44M 28.80% | 2.29M 57.95% | 2.61M 14.25% | 2.92M 11.82% | 2.18M 25.52% | 2.80M 28.66% | |
change in working capital | -5.09M - | -14.45M 183.80% | 8.10M 156.03% | 2.02M 75.09% | -3.17M 257.21% | -6.58M 107.51% | -41K 99.38% | 914K 2,329.27% | 550K 39.82% | 29K 94.73% | |
accounts receivables | 6.64M - | 347K - | -1.11M 421.33% | 638K 157.22% | 503K 21.16% | ||||||
inventory | -616K - | -606K - | 270 100.04% | 610 125.93% | 304 50.16% | ||||||
accounts payables | 940K - | 529K 43.72% | 3.12M 490.36% | -65K 102.08% | -4.03M 6,098.46% | -393K 90.25% | -786K 100% | -250K 68.19% | -110K 56.00% | 29K 126.36% | |
other working capital | -6.03M - | -14.98M 148.34% | -1.05M 92.98% | 2.08M 298.10% | 1.12M 46.35% | -5.07M 554.10% | 106.39K 102.10% | 660.70K 521.01% | 660K 0.11% | -29K 104.39% | |
other non cash items | 8.64M - | 18.65M 115.97% | 1.04M 94.41% | 600K 42.47% | 756K 26% | 2.13M 182.01% | 154K 92.78% | 46K 70.13% | -52K 213.04% | 398K 865.38% | |
net cash provided by operating activities | -39.51M - | -49.86M 26.19% | -56.88M 14.09% | -58.77M 3.32% | -43.27M 26.37% | -19.82M 54.20% | -12.54M 36.75% | -24.13M 92.47% | -25.53M 5.79% | -26.77M 4.87% | |
investments in property plant and equipment | -1.21M - | -1.43M 18.08% | -966K 32.45% | -319K 66.98% | -22K 93.10% | -244K 1,009.09% | -11K 95.49% | -251K 2,181.82% | -361K 43.82% | -613K 69.81% | |
acquisitions net | 65K - | 67K 3.08% | 53K 20.90% | 16K 69.81% | 318K - | 14.76K - | |||||
purchases of investments | -113.42M - | -78.40M 30.87% | -65.11M 16.95% | -55.69M 14.47% | -32.76M - | -4.90M 85.05% | |||||
sales maturities of investments | 85.42M - | 101.31M 18.60% | 101.39M 0.08% | 69.94M 31.02% | 46.54M 33.46% | 18M - | 20M 11.11% | ||||
other investing activites | -65K - | -67K 3.08% | -53K 20.90% | -16K 69.81% | -14.76K - | 3K 120.33% | |||||
net cash used for investing activites | -29.21M - | 21.48M 173.53% | 35.31M 64.43% | 13.94M 60.53% | 46.52M 233.80% | 74K 99.84% | -11K 114.86% | -251K 2,181.82% | -15.12M 5,923.90% | 14.49M 195.84% | |
debt repayment | -167K - | -3.34M - | -2.24M 32.97% | -10.28M 358.79% | -80K 99.22% | ||||||
common stock issued | 88.38M - | 7.17M 91.88% | 641K 91.06% | 43.41M 6,672.39% | 219K 99.50% | 42.17M 19,155.71% | 19.12M 54.65% | 53.79M 181.29% | 4.49M 91.65% | 1.12M 75.13% | |
common stock repurchased | |||||||||||
dividends paid | |||||||||||
other financing activites | -142K - | -155K 9.15% | 20.08M 13,053.55% | 4K 99.98% | 293K 7,225% | 3K 98.98% | 667K 22,133.33% | 26K 96.10% | 10.70M - | ||
net cash used provided by financing activities | 88.24M - | 7.02M 92.05% | 20.55M 192.89% | 43.41M 111.24% | -2.83M 106.52% | 39.93M 1,511.06% | 9.51M 76.18% | 53.74M 464.88% | 4.49M 91.64% | 11.82M 163.10% | |
effect of forex changes on cash | |||||||||||
net change in cash | 19.52M - | -21.37M 209.46% | -1.02M 95.23% | -1.42M 39.55% | 416K 129.25% | 20.19M 4,752.40% | -3.03M 115.03% | 29.36M 1,067.63% | -36.16M 223.15% | -461K 98.72% | |
cash at beginning of period | 17.81M - | 37.33M 109.62% | 15.96M 57.24% | 14.94M 6.38% | 13.52M 9.52% | 13.94M 3.08% | 34.12M 144.86% | 31.09M 8.89% | 60.45M 94.44% | 24.29M 59.81% | |
cash at end of period | 37.33M - | 15.96M 57.24% | 14.94M 6.38% | 13.52M 9.52% | 13.94M 3.08% | 34.12M 144.86% | 31.09M 8.89% | 60.45M 94.44% | 24.29M 59.81% | 23.83M 1.90% | |
operating cash flow | -39.51M - | -49.86M 26.19% | -56.88M 14.09% | -58.77M 3.32% | -43.27M 26.37% | -19.82M 54.20% | -12.54M 36.75% | -24.13M 92.47% | -25.53M 5.79% | -26.77M 4.87% | |
capital expenditure | -1.21M - | -1.43M 18.08% | -966K 32.45% | -319K 66.98% | -22K 93.10% | -244K 1,009.09% | -11K 95.49% | -251K 2,181.82% | -361K 43.82% | -613K 69.81% | |
free cash flow | -40.72M - | -51.29M 25.95% | -57.85M 12.79% | -59.09M 2.15% | -43.30M 26.73% | -20.07M 53.66% | -12.55M 37.47% | -24.38M 94.30% | -25.89M 6.19% | -27.38M 5.77% |
All numbers in USD (except ratios and percentages)